(Q33714948)

28 July 2017

title

Acute ischemic stroke therapy (English)

1 reference

28 July 2017

Nils Henninger

1

1 reference

28 July 2017

Rajat Kumar

series ordinal

2

1 reference

28 July 2017

Marc Fisher

series ordinal

3

1 reference

28 July 2017

publication date

1 October 2010

1 reference

Expert Review of Cardiovascular Therapy

28 July 2017

published in

1 reference

28 July 2017

volume

8

1 reference

28 July 2017

issue

10

1 reference

28 July 2017

page(s)

1389-1398

1 reference

What are high-flow and low-flow oxygen delivery systems?

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Guidelines for the Early Management of Adults With Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Ultraearly thrombolysis in acute ischemic stroke is associated with better outcome and lower mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Blood pressure and clinical outcomes in the International Stroke Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Blood Pressure After Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Blood pressure treatment in acute ischemic stroke: a review of studies and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

High blood pressure in acute stroke and subsequent outcome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Effects of blood pressure levels on case fatality after acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Factors influencing acute blood pressure values in stroke subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

High blood pressure in acute ischaemic stroke--broadening therapeutic horizons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

The role of hyperglycemia in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Intensive insulin therapy in the medical ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Intensive versus conventional glucose control in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

HMG-CoA reductase inhibitors improve acute ischemic stroke outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Statin treatment withdrawal in ischemic stroke: a controlled randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Acute ischaemic stroke and infection: recent and emerging concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: the Mannheim infection in stroke study (MISS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

The ischemic penumbra: a new opportunity for neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

The ischemic penumbra: operationally defined by diffusion and perfusion MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Granulocyte-colony stimulating factor delays PWI/DWI mismatch evolution and reduces final infarct volume in permanent-suture and embolic focal cerebral ischemia models in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Perfusion CT helps decision making for thrombolysis when there is no clear time of onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Pathophysiology and therapy of experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Exciting, radical, suicidal: how brain cells die after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Treatment of acute ischemic stroke: role of ischemic tolerance in intravenous and endovascular therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

New targets for established proteins: exploring G-CSF for the treatment of stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.128

21 January 2018

Identifiers

DOI

10.1586/ERC.10.128

1 reference

28 July 2017

1 reference